Stay updated on Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Sign up to get notified when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.

Latest updates to the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page
- Check5 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error, and its footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check12 days agoChange DetectedA site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The clinical trial record remains unavailable on the page.SummaryDifference1%

- Check19 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check26 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page has been replaced with a 403 Forbidden error page, effectively blocking access to the study record details. Visible additions include a 403 header and related HTML, signaling an access restriction rather than new study information.SummaryDifference19%

- Check69 days agoChange DetectedAdded a note showing the 2019 ( U.S. NIH Grant/Contract ) in the study identifiers, and updated the page version to v3.6.6 (replacing v3.6.5).SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.